GN Store Nord AS GGNDF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $15.40
- Day Range
- $15.31–15.84
- 52-Week Range
- $12.80–17.90
- Bid/Ask
- $8.60 / $66.65
- Shares Outstanding
- 145.61M
- Market Cap
- $2.23B
- Volume/Avg
- 7,014 / 5,624
Key Statistics
- Price/Earnings (Normalized)
- 142.42
- Price/Sales
- 1.28
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
GN Store Nord is a Danish company offering medical and audio solutions. The group comprises three businesses: hearing (about 40% of sales), enterprise (40%), and gaming (20%). GN Hearing offers hearing aids and competes globally with Sonova, Demant, Starkey, and WS Audiology (formerly Sivantos and Widex). GN Enterprise provides headsets and speakerphones to the enterprise market, including contact centers and offices. GN recently acquired SteelSeries, a provider of gaming accessories such as headsets and keyboards, thereby forming the gaming division. The company has positioned itself as a major player in the Unified Communication-enabled headsets market. The firm's premium brands are Resound in hearing, Jabra in headsets, and SteelSeries in gaming.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 7,736
- Website
- https://www.gn.com
Valuation
Metric | GGNDF |
|---|---|
Price/Earnings (Normalized) | 142.42 |
Price/Book Value | 1.40 |
Price/Sales | 1.28 |
Price/Cash Flow | 6.25 |
Price/Earnings
GGNDF
Financial Strength
Metric | GGNDF |
|---|---|
Quick Ratio | 0.38 |
Current Ratio | 1.86 |
Interest Coverage | 2.00 |
Quick Ratio
GGNDF
Profitability
Metric | GGNDF |
|---|---|
Return on Assets (Normalized) | 1.56% |
Return on Equity (Normalized) | 4.38% |
Return on Invested Capital (Normalized) | 3.23% |
Return on Assets
GGNDF
Medical Devices Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Abbott Laboratories ABT | LOCK|@b?TlJ | LOCK|dtj! | $188B | |||
| Medtronic PLC MDT | LOCK|SN?LYb& | LOCK|My&r | $132B | |||
| Stryker Corp SYK | LOCK|G?m&#ch^ | LOCK|sp | $118B | |||
| Boston Scientific Corp BSX | LOCK|N%w?&% | LOCK|$>gbh | $64B | |||
| Edwards Lifesciences Corp EW | LOCK|fdNL>^Kc | LOCK|gX?sg | $62B | |||
| GE HealthCare Technologies Inc Common Stock GEHC | LOCK|ldFhnzT | LOCK|fc | $38B | |||
| DexCom Inc DXCM | LOCK|p#<Ptt& | LOCK|v$#?h | $31B | |||
| Koninklijke Philips NV ADR PHG | LOCK|$!$ | LOCK|^Zn | $30B | |||
| Steris PLC STE | LOCK|FZ!Ry# | LOCK|XqT> | $26B | |||
| Zimmer Biomet Holdings Inc ZBH | LOCK|Q?bN^S# | LOCK|#& | $20B |
United States